The securitisation of pandemic influenza: Framing, security and public policy

Global Public Health

Volumn 7, Issue SUPPL. 2, 2012, Pages

  Kamradt Scott, Adam ^a,b   McInnes, Colin ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

framing; global health; pandemic influenza; public policy; securitisation

Indexed keywords

ARTICLE; HEALTH CARE POLICY; HEALTH ECONOMICS; HUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PUBLIC HEALTH; SAFETY; THREAT;

COMMUNICABLE DISEASE CONTROL; HEALTH POLICY; HUMANS; INFLUENZA, HUMAN; MODELS, THEORETICAL; PANDEMICS; POLITICS; PUBLIC HEALTH; PUBLIC POLICY; RISK ASSESSMENT; RISK MANAGEMENT; WORLD HEALTH;

EID: 84871006097     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441692.2012.725752     Document Type: Article

References (76)

1. Amelio, R., Biselli, R., Cali, G. and Peragallo, M. 2002. Vaccination policies in the military: an insight on influenza. Vaccine, 20(Suppl. 5): B36-B39. doi:10.1016/S0264-410X(02)00506-6
2. Balzacq, T. 2005. The three faces of securitization: political agency, audience and context. European journal of international relations, 11(2): 171-201. doi:10.1177/1354066105052960
3. Balzacq, T. 2011. "A theory of securitization: origins, core assumptions, and variants". In Securitization theory: how security problems emerge and dissolve, Edited by: Balzacq, T. Abingdon, UK: Routledge.
4. Beveridge, W. 1977. Influenza: the last great plague, London: Heinemann.
5. Booth, K. 2007. Theory of world security, Cambridge: Cambridge University Press.
6. Buzan, B., Waever, O. and de Wilde, J. 1998. Security: a new framework for analysis, Boulder, CO: Lynne Rienner.
7. Campbell, A. 2004. The SARS commission interim report: SARS and public health in Ontario. Ontario, Canada: The Ministry of Health and Long-Term Care. Available from: http://www.health.gov.on.ca/english/public/pub/ministry_reports/campbell04/campbell04.pdf [Accessed 6 Sept 2011].
8. Campbell, D. 2008. The visual economy of HIV/AIDS: a report for the AIDS, security and conflict initiative. Available from: www.david-campbell.org/wp-content/documents/Visual_Economy_of_HIV_AIDS.pdf [Accessed 6 Aug 2012].
9. Ciutǎ, F. 2009. Security and the problem of context: a hermeneutical critique of securitisation theory. Review of international studies, 35(2): 301-326. doi:10.1017/S0260210509008535
10. Collins, A. 2006. Contemporary security studies. Oxford: Oxford University Press.
11. Davies, S. 2008. Securitizing infectious disease. International affairs, 84(2): 295-313. doi:10.1111/j.1468-2346.2008.00704.x
12. Davies, S. 2010. Global politics of health, Oxford: Polity.
13. DeLacy, M. 1993. Influenza research and the medical profession in eighteenth-century Britain. Albion: a quarterly journal concerned with British studies, 25(1): 37-66. doi:10.2307/4051039
14. Elbe, S. 2006. Should HIV/AIDS be securitised? The ethical dilemmas of linking HIV/AIDS and security. International studies quarterly, 50(1): 119-144. doi:10.1111/j.1468-2478.2006.00395.x
15. Elbe, S. 2009. Virus alert: security, governmentality and the AIDS pandemic, New York: Columbia University Press.
16. Elbe, S. 2010. Security and global health: toward the medicalization of insecurity, Cambridge: Polity.
17. Elbe, S. 2011. Pandemics on the radar screen: health security, infectious disease and the medicalisation of insecurity. Political studies, 59(4): 848-866. doi:10.1111/j.1467-9248.2011.00921.x
18. Enemark, C. 2009. Is pandemic flu a security threat?. Survival, 51(1): 191-214. doi:10.1080/00396330902749798
19. Fearon, J. 1991. Counterfactuals and hypothesis testing in political science. World politics, 43(2): 169-195. doi:10.2307/2010470
20. Francis, T. Jr. 1947. A consideration of vaccination against influenza. The Milbank memorial fund quarterly, 25(1): 5-20. doi:10.2307/3347981
21. Francis, T. Jr. 1958. Influenza. Preventive Medicine in World War II, vol. IV. Washington, DC: US Government Printing Office. Available from: http://history.amedd.army.mil/booksdocs/wwii/PM4/CH04.Influenza.htm [Accessed 29 Mar 2012].
22. Garrett, L. 1994. The coming plague: newly emergent diseases in a world out of balance, New York: Farrar, Straus and Giroux.
23. Garrett, L. 2005a. The next pandemic?. Foreign affairs, 84(4): 3-23. doi:10.2307/20034417
24. Garrett, L. 2005b. Responding to the threat of global, virulent influenza. Written testimony before the United States Senate Committee on Foreign Relations, 9 November 2005. Available from: http://foreign.senate.gov/imo/media/doc/GarrettTestimony051109.pdf [Accessed 5 Sept 2011].
25. Gensheimer, K.F., Fukuda, K., Brammer, L., Cox, N., Patriarca, P.A., and Strikas, R.A. 1999. Preparing for pandemic influenza: the need for enhanced surveillance. Emerging infectious diseases, 5 2. Available from: http://www.cdc.gov/ncidod/eid/vol5no2/gensheimer.htm [Accessed 30 Aug 2011]. doi:10.3201/eid0502.990219
26. Gensheimer, K.F., Meltzer, M.I., Postema, A.S. and Fukuda, K. 2003. Influenza pandemic preparedness. Emerging infectious diseases, 9(12): 1645-1648. doi:10.3201/eid0912.030289
27. Glezen, W.P. 1996. Emerging infections: pandemic influenza. Epidemiologic reviews, 18(1): 64-75. doi:10.1093/oxfordjournals.epirev.a017917
28. Gust, I.D., Hampson, A.W. and Lavanchy, D. 2001. Planning for the next pandemic of influenza. Reviews in medical virology, 11(1): 59-70. doi:10.1002/rmv.301
29. Hansen, L. 2000. The little mermaid's silent security dilemma and the absence of gender in the Copenhagen school. Millennium: journal of international studies, 29(2): 285-306. doi:10.1177/03058298000290020501
30. Hirsch, A. 1883. Handbook of geographical and historical pathology: volume 1-acute infective diseases, London: New Sydenham Society.
31. Hodge, J. 2010. Global legal triage in response to the 2009 H1N1 outbreak. Minnesota journal of law, science & technology, 11(2): 599-628.
32. Kamradt-Scott, A. 2010. The WHO secretariat, norm entrepreneurship, and global disease outbreak control. Journal of international organizations studies, 1(1): 72-89.
33. Kamradt-Scott, A. 2012. Changing perceptions of pandemic influenza and public health responses. American journal of public health policy, 102(1): 90-98. doi:10.2105/AJPH.2011.300330
34. Katona, P., Sullivan, J., and Intrilligator, M. 2010. Global biosecurity: threats and responses. London: Routledge.
35. Katz, R. and Fischer, J. 2010. The revised international health regulations: a framework for global pandemic response. Global health governance, 3(2): 1-18.
36. Kavet, J. 1977. A perspective on the significance of pandemic influenza. American journal of public health, 67(11): 1063-1070. doi:10.2105/AJPH.67.11.1063
37. Kelle, A. 2007. Securitization of international public health. Global governance, 13: 217-235.
38. Koblentz, G.D. 2009. The threat of pandemic influenza: why today is not 1918. World medical & health policy, 1 1, Article 9, doi:10.2202/1944-2858.1007/.
39. Koblentz, G.D. 2010. Biosecurity reconsidered: calibrating biological threats and responses. International security, 34(4): 96-132. doi:10.1162/isec.2010.34.4.96
40. Lam, P.Y. 2008. Avian influenza and pandemic influenza preparedness in Hong Kong. Annals academy of medicine Singapore, 37(6): 489-496.
41. Marston, G. and Watts, R. 2003. Tampering with the evidence: a critical appraisal of evidence-based policy-making. The drawing board: an Australian review of public affairs, 3(3): 143-163.
42. McDonald, M. 2008. Securitization and the construction of security. European journal of international relations, 14(4): 563-587. doi:10.1177/1354066108097553
43. McInnes, C. and Lee, K. 2005. Health and security. Tiddsskriftet Politik, 8(1): 33-44.
44. McInnes, C. and Lee, K. 2006. Health, security and foreign policy. Review of international studies, 32(1): 5-23. doi:10.1017/S0260210506006905
45. McInnes, C. and Rushton, S. 2012. HIV/AIDS and securitization theory. European journal of international relations. Online first doi:10.1177/1354066111425258.
46. McSweeney, B. 1996. Identity and security: Buzan and the Copenhagen School. Review of international studies, 22(1): 81-93. doi:10.1017/S0260210500118467
47. Meltzer, M.I., Cox, N. and Fukuda, K. 1999. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerging infectious diseases, 5(5): 669-671. doi:10.3201/eid0505.990507
48. Mounier-Jack, S., Jas, R. and Coker, R. 2007. Progress and shortcomings in European national strategic plans for pandemic influenza. Bulletin of the World Health Organization, 85(12): 923-929. doi:10.2471/BLT.06.039834
49. Mudd, S. 1944. Air-borne infections. British medical journal, 2(4369): 444-445. doi:10.1136/bmj.2.4369.444-a
50. NIC (National Intelligence Council), 2000. Global infectious disease threats and its implications for the United States. National Intelligence Estimate NIE 99-17D. Available from: http://www.dni.gov/nic/special_globalinfectious.html [Accessed 5 Sept 2011].
51. Nelson, A.J. 1958. Evaluation of Asian influenza vaccine in an industrial population. Canadian medical association journal, 79: 888-891.
52. Obama, B. and Lugar, R., 2005. Grounding a pandemic. New York Times, 6 June, Available from: http://www.nytimes.com/2005/06/06/opinion/06obama.html [Accessed 2 Sept 2011].
53. Osterholm, M.T. 2005. Preparing for the next pandemic. New England journal of medicine, 352(18): 1839-1842. doi:10.1056/NEJMp058068
54. Osterholm, M.T. 2007. Unprepared for a pandemic. Foreign affairs, 86(2): 47-57.
55. Owens, A., Canas, L., Russell, K., Neville, J., Pavlin, J., MacIntosh, V., Gray, G. and Gaydos, J. 2009. Department of Defense Global Laboratory-based Influenza Surveillance: 1998-2005. American journal of preventive medicine, 37(3): 235-241. doi:10.1016/j.amepre.2009.04.022
56. Parsons, H.F. 1891. The influenza epidemics of 1889-90 and 1891, and their distribution in England and Wales. British medical journal, 2(1597): 303-308. doi:10.1136/bmj.2.1597.303
57. Payne, A.M. 1953. The influenza programme of WHO. Bulletin of the world health organization, 8(5-6): 755-774.
58. Potter, C.W. 1991. "Chronicle of influenza pandemics". In Textbook of influenza, Edited by: Webster, R. London: Blackwell Science.
59. Pyhälä, R. 1980. Protection by a polyvalent influenza vaccine and persistence of homologous and heterologous H1 antibodies during a period of two epidemic seasons. Journal of hygiene Cambridge, 84(2): 237-245. doi:10.1017/S0022172400026735
60. Snacken, R., Kendal, A.P., Haaheim, L.R. and Wood, J.M. 1998. The next influenza pandemic: lessons from Hong Kong, 1997. Emerging infectious diseases, 5(2): 195-203. doi:10.3201/eid0502.990202
61. Stephenson, N. and Jamieson, M. 2009. Securitizing health: Australian newspaper coverage of pandemic influenza. Sociology of health & illness, 31(4): 525-539. doi:10.1111/j.1467-9566.2009.01162.x
62. Stritzel, H. 2007. Towards a theory of securitization: Copenhagen and beyond. European journal of international relations, 13(3): 357-383. doi:10.1177/1354066107080128
63. Sueker, J., Blazes, D., Johns, M., Blair, P., Sjoberg, P., Tjaden, J., Montgomery, J., Pavlin, J., Schnabel, D., Eick, A., Tobias, S., Quintana, M., Vest, K., Burke, R., Lindler, L., Mansfield, J., Erickson, R., Russell, K. and Sanchez, J. 2010. Influenza and respiratory disease surveillance: the US military's global laboratory-based network. Influenza and other respiratory viruses, 4(3): 155-161. doi:10.1111/j.1750-2659.2010.00129.x
64. Tam, T. 1999. Preparing for influenza epidemics and pandemics in the new millennium. Canadian journal of public health, 90(5): 293-319.
65. UK Government, 2009. Explanatory memorandum to the medicines for human use (miscellaneous amendments) Regulations 2009 No. 1164, the medicines for human use (prescribing) (miscellaneous amendments) Order 2009 No. 1165, the National Health Service (charges) (amendments relating to pandemic influenza) Regulations 2009 No. 1166. Available from: http://www.legislation.gov.uk/uksi/2009/1165/pdfs0/uksiem_20091165_en.pdf [Accessed 6 Sept 2011].
66. UNSIC and World Bank, 2010. Fifth global progress report 2010: a framework for sustaining momentum. Bangkok: World Bank.
67. Vance, M. 2011. Disease mongering and the fear of pandemic influenza. International journal of health services, 41(1): 95-115. doi:10.2190/HS.41.1.g
68. Vuori, J. 2008. Illocutionary logic and strands of securitization: applying the theory of securitization to the study of non-democratic political orders. European journal of international relations, 14(1): 65-99. doi:10.1177/1354066107087767
69. Walters, J.H. 1978. Influenza 1918: the contemporary perspective. Bulletin of the New York academy of medicine, 54(9): 855-864.
70. Webster, R.G. and Govorkova, E.A. 2006. H5N1 influenza-continuing evolution and spread. New England journal of medicine, 355(21): 2174-2178. doi:10.1056/NEJMp068205
71. WHO (World Health Organization), 1999. Influenza pandemic plan. The role of WHO and guidelines for national and regional planning. Geneva: WHO. Available from: http://whqlibdoc.who.int/hq/1999/WHO_CDS_CSR_EDC_99.1.pdf [Accessed 30 Aug 2011].
72. WHO, 2007. World Health Report 2007: A safer future: global public health security in the 21st century. Geneva: WHO.
73. WHO, 2011. WHO global influenza surveillance network. Available from: http://www.who.int/csr/disease/influenza/surveillance/en/index.html [Accessed 20 Sept 2011].
74. WHO, 2012. Technical consultation on H5N1 research issues-consensus points. Available from: http://www.who.int/influenza/human_animal_interface/consensus_points/en/index.html [Accessed 29 Mar 2012].
75. Williams, M.C. 2003. Words, images, enemies: securitization and international politics. International studies quarterly, 47(4): 511-531. doi:10.1046/j.0020-8833.2003.00277.x
76. Zimmet, P. and Alberti, K.G. 2006. Introduction: globalization and the non-communicable disease epidemic. Obesity, 14(1): 1-3. doi:10.1038/oby.2006.1